Effects of two natural medicine formulations on irritable bowel syndrome symptoms: A pilot study

Journal of Alternative and Complementary Medicine

Volumn 16, Issue 10, 2010, Pages 1065-1071

  Hawrelak, Jason A ^a,b   Myers, Stephen P ^b  

^a Goulds Naturopathica   (Australia)

^b SOUTHERN CROSS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GASTROINTESTINAL AGENT; HERBACEOUS AGENT; LACTULOSE;

ABDOMINAL PAIN; ADULT; AGRIMONIA; AGRIMONIA EUPATORIA; ARTICLE; AUSTRALIA; BARK; BLOATING; CINNAMOMUM ZEYLANICUM; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DEFECATION HABIT; DIARRHEA; DRUG FORMULATION; DRUG TOLERABILITY; ELM; FECES; FEMALE; FLATULENCE; FRUIT; GLYCYRRHIZA GLABRA; HARD FECES; HUMAN; IRRITABLE COLON; LABORATORY TEST; NAUSEA; OAT; PATIENT COMPLIANCE; PILOT STUDY; PLANT ROOT; POWDER; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; ULMUS FULVA; VACCINIUM MYRTILLUS;

ABDOMINAL PAIN; ADULT; AVENA SATIVA; CONSTIPATION; DEFECATION; DIARRHEA; FLATULENCE; FRUIT; GLYCYRRHIZA; HUMANS; IRRITABLE BOWEL SYNDROME; LACTULOSE; PHYTOTHERAPY; PILOT PROJECTS; PLANT BARK; PLANT EXTRACTS; PLANT ROOTS; SEEDS; ULMUS; VACCINIUM MYRTILLUS;

EID: 77958177254     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2009.0090     Document Type: Article

References (31)

1. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999;45(suppl 2):43-47.
2. Wilson S, Roberts L, Roalfe A, et al. Prevalence of irritable bowel syndrome: A community survey. Br J Gen Prac 2004;54:495-502.
3. Saito YA, Talley NJ, Melton LJ, et al. The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates. Neurogastroenterol Mot 2003;15:687-694.
4. Hillila MT, Farkkila MA. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a nonselected adult population. Aliment Pharmacol Ther 2004;20:339-345.
5. Dapoigny M, Bellanger J, Bonaz B, et al. Irritable bowel syndrome in France: A common, debilitating and costly disorder. Eur J Gastroenterol Hepatol 2004;16:995-1001.
6. Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992;304:87-90.
7. Everhart JE, Renault PF. Irritable bowel syndrome in officebased practice in the United States. Gastroenterology 1991;100:998-1005.
8. Whorwell PJ. Irritable bowel syndrome: A drug development minefield. Drugs of Today 2001;37:761-765.
9. Akehurst R, Kaltenthaler E. Treatment of irritable bowel syndrome: A review of randomised controlled trials. Gut 2001;48:272-282.
10. Whitehead WE. Patient subgroups in irritable bowel syndrome that can be defined by symptom evaluation and physical examination. Am J Med 1999;107:33S-40S.
11. Schulz V, Hansel R, Tyler VE. Rational Phytotherapy: A Physicians Guide to Herbal Medicine. Berlin: Springer, 2000:191-203.
12. Herbal Drugs and Phytopharmaceuticals. Stuttgart: Medpharm Scientific Publishers, 2001:148-151.
13. van Wyk BE, Wink M. Medicinal Plants of the World. Pretoria: Briza Publications, 2004:82.
14. Chevallier A. Encyclopedia of Medicinal Plants. London: Dorling Kindersley, 2001:145.
15. Bradley PR, ed. British Herbal Compendium. Bournemouth: British Herbal Medicine Association, 1992:204.
16. Welch RW. Can dietary oats promote health? Br J Biomed Sci 1994;51:41-44.
17. Chevallier A. Encyclopedia of Medicinal Plants. London: Dorling Kindersley, 2001:162.
18. Mills S. The Essential Book of Herbal Medicine. London: Arkana, 1991:138.
19. Terada A, Hara H, Kataoka M, et al. Effect of lactulose on the composition and metabolic activity of the human faecal flora. Microb Ecol Health Dis 1992;5:43-50.
20. Ballongue J, Schumann C, Quignon P. Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scand J Gastroenterol 1997;32(suppl 222):41-44.
21. Kontula P, von Wright A, Mattila-Sandholm T. Oat bran β- gluco-and xylo-oligosaccharides as fermentative substrates for lactic acid bacteria. Int J Food Microbiol 1998;45:163-169.
22. Barcelo A, Claustre J, Moro F, et al. Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon. Gut 2000;46:218-224.
23. Satchithanandam S, Vargofcak-Apker M, Calvert RJ, et al. Alteration of gastrointestinal mucin by fiber feeding in rats. J Nutr 1990;120:1179-1184.
24. Lust JB. Raw Juice Therapy. London: Thorsons Publishers Ltd., 1958:64-65.
25. Palaiseul J. The Green Guide to Health from Plants. London: Book Club Associates, 1977:29-31.
26. Bensoussan A, Talley NJ, Hing M, et al. Treatment of irritable bowel syndrome with Chinese herbal medicine. JAMA 1998;280:1585-1589.
27. White A, Ernst E. The case for uncontrolled clinical trials: A starting point for the evidence base for CAM. Complement Ther Med 2001;9:111-115.
28. Klein KB. Controlled treatment trials in the irritable bowel syndrome: A critique. Gastroenterology 1988;95:232-241.
29. Spiller RC. Problems and challenges in the design of irritable bowel syndrome clinical trials: Experience from published trials. Am J Med 1999;107:91S-97S.
30. Choi YK, Johlin FC, Summers RW, et al. Fructose intolerance: An under-recognized problem. Am J Gastroenterol 2003;98:1348-1353.
31. Kneepkens CMF, Jakbos C, Douwes AC. Apple juice, fructose, and chronic nonspecific diarrhea. Eur J Pediatr 1989;148:571-573.